New drug to treat patients in the early stages of Alzheimer’s

News published on August 23, 2024

This week, a product licence for the medicine lecanemab (Leqembi) was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adult patients in the early stages of Alzheimer’s disease.

Dementia support pop-up coming to Aylesbury

News published on August 21, 2024

There will be an opportunity to find out more about local services that support people with dementia on Wednesday 28 August in Aylesbury.

Largest ever trial of ketamine-assisted therapy for alcohol disorder now recruiting  

News published on August 9, 2024

The largest ever trial to investigate whether ketamine-assisted therapy could help people with alcohol problems stop drinking is now recruiting participants.  

OHFT Researchers, staff and partners meet the Cowley community

News published on August 8, 2024

Recently researchers, staff and colleagues from across Oxfordshire research held an informal drop in engagement session for women and children in Cowley.

How was your mental health care? 2024 Community Mental Health Survey

News published on August 2, 2024

The NHS has launched a major survey on people’s experiences of using mental health services.

Collective action by GP services

News published on August 1, 2024

The NHS is asking the public to still come forward as usual for care during collective action by GP services which starts today (Thursday 1 August).

New shingles vaccine could reduce risk of dementia – major study indicates

News published on July 25, 2024

The new recombinant shingles vaccine ‘Shingrix’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine.

We Did It! Smiles all round at 10th annual Have a Go Festival

News published on July 24, 2024

This year’s event marked a decade of providing people with a learning disability the chance overcome some of the barriers they can experience when taking part in sports.

Recruitment open for healthy participants in the OxSENSE study

News published on July 19, 2024

University of Oxford and Oxford Health Biomedical Research Centre (OH BRC) supported researchers are recruiting participants for the Oxford Semaglutide and Cognition (OxSENSE) Study. The study is investigating the effects of a single-dose of semaglutide on cognition and energy in healthy volunteers.

New Therapeutic Approaches in Translational Mental Health

News published on July 18, 2024

Academia Meets Industry – Grand Challenges and New Horizons

Monday 16 September 2024, Mathematical Institute, Oxford